Omeprazol Teva

Quick links to important sections

Omeprazol Teva

Selected form

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Omeprazol Teva

Quick Facts

Property Description
Active ingredient Omeprazole
Form Gastro-resistant capsule or Enteric-coated tablet
Pharmacological class Proton Pump Inhibitor (PPI)
Common use Reducing gastric acid production
Origin Synthetic, benzimidazole derivative

What Type of Medicine is Omeprazol Teva?

Omeprazol Teva is a widely used branded generic medication with the active substance Omeprazole, which belongs to the specialized class of drugs known as Proton Pump Inhibitors (PPIs). This class is clinically recognized as a foundational treatment for conditions involving excessive stomach acid production. The compound is synthetic and chemically categorized as a substituted benzimidazole derivative. Unlike older agents that provide temporary relief, the PPI class offers a highly specific and foundational method of acid suppression, setting it apart as a preferred agent for consistent long-term acid management.

Why Is Omeprazol Teva a Gastro-Resistant Capsule?

The medicine is commonly supplied by the manufacturer Teva as a gastro-resistant capsule or enteric-coated tablet, a necessary pharmaceutical formulation that ensures the integrity of the active substance. This protective design is vital because Omeprazole is highly unstable and would be destroyed by the corrosive gastric acid if released immediately in the stomach. This specialized oral formulation, which contains multiple individually coated granules or enteric-coated pellets, ensures the compound passes safely through the stomach for optimal absorption. This ensures the medicine is fully available to reach its target cells in the gastric lining to execute its intended function.

What Is the General Purpose of Omeprazole?

The overall therapeutic purpose of Omeprazole is to provide potent and prolonged suppression of gastric acid production. This function is critical for minimizing the damaging effects associated with the presence of excessive stomach acid. By significantly reducing acidity, the medicine helps create an environment where the body's natural healing processes can repair irritation and damage to the esophageal and stomach lining. Its primary general benefit is consistent and powerful acid suppression, often used in scenarios where a patient requires reliable relief from recurrent acid exposure.

Regulatory References

  1. Omeprazole - StatPearls - NCBI Bookshelf - NIH
  2. Public Assessment Report for Omeprazol Sandoz

What side effects are possible with Omeprazol Teva?

Possible Side Effects and Safety Information

The safety profile of Omeprazol Teva is based on documented adverse reactions categorized by frequency and the body system affected, strictly according to official regulatory data.


Frequency-Classified Adverse Reactions

Classification Examples of Documented Side Effects
Common (1–10%) Headache, abdominal pain, diarrhea, flatulence, nausea, vomiting, constipation.
Uncommon (0.1–1%) Insomnia, dizziness, skin rash, itching (pruritus), malaise, increased liver enzymes.
Rare (<0.1%) Low blood cell counts (leukopenia, thrombocytopenia), agitation, blurred vision, dry mouth, hepatitis, hair loss (alopecia), joint pain (arthralgia).

Serious and Time-Related Safety Considerations

Serious Adverse Reactions officially listed include rare but severe events such as severe allergic reactions (anaphylaxis), severe skin conditions (e.g., Stevens-Johnson syndrome), acute tubulointerstitial nephritis (kidney inflammation), and hepatic failure.

Duration- or Exposure-Related Safety Patterns are also documented:

  • Long-term use (typically one year or more) is associated with an increased risk of osteoporosis-related fractures of the hip, wrist, or spine.
  • Prolonged treatment may lead to Hypomagnesaemia (low magnesium levels) and a potential Vitamin B-12 deficiency.

Safety Restrictions and Limitations

Symptomatic response to omeprazole does not exclude the presence of gastric malignancy; proper evaluation to rule out malignancy is a required precaution. Omeprazole use may also be associated with an increased risk for gastrointestinal infections (such as Clostridium difficile-associated diarrhea).

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documents describe the manifestations of omeprazole overdose as typically transient and without reported serious clinical outcomes, even at intake levels significantly above the therapeutic range. No severe clinical outcome has been reported in documented cases.

Documented Clinical Manifestations

Overdose may present with a specific, reported symptom profile affecting several physiological systems. These signs can include nausea, vomiting, and abdominal pain (gastrointestinal), alongside central nervous system effects such as headache, drowsiness, and confusion. Autonomic and cardiovascular manifestations reported include tachycardia (fast heart rate), flushing, and diaphoresis (sweating). Blurred vision may also occur.

Required Emergency Actions

Regulatory guidance mandates that individuals seek emergency medical attention immediately upon suspected overdose or contact a Poison Control center. Urgent intervention is required; specifically, emergency services must be called if the individual experiences severe symptoms such as seizure, collapse, trouble breathing, or inability to be awakened.

Official Treatment Principles

Management is defined as symptomatic and supportive treatment. The official label states that no specific antidote is known for omeprazole overdosage. Furthermore, due to the substance being extensively protein bound, regulatory information notes that omeprazole is not readily dialyzable.

Therapeutic Uses of Omeprazol Teva

Quick Facts: Omeprazol Teva

  • Primary Use: Managing symptoms associated with excess stomach acid production.
  • Therapeutic Domain: Assists in the treatment of specific gastric and esophageal conditions.
  • Key Action: May reduce acid secretion within the stomach.

Omeprazol Teva is a medication primarily used to help manage conditions linked to increased stomach acid. Its therapeutic role involves addressing symptoms and facilitating the healing process in the upper gastrointestinal tract.

Main Uses and Benefits

Omeprazol Teva is commonly indicated for the short-term treatment of active duodenal and gastric ulcers. By influencing acid production, the medication may assist in relieving the pain and discomfort associated with these conditions, potentially allowing the ulcer to heal.

Furthermore, this medication is utilized for the management of Gastroesophageal Reflux Disease (GERD). GERD is characterized by the backflow of stomach acid into the esophagus, which may cause symptoms like heartburn. Omeprazol Teva may provide symptomatic relief and is used to treat erosive esophagitis that is a consequence of GERD. It also has a role in the long-term management of conditions where excessive acid is produced, such as Zollinger-Ellison syndrome.

This medication should be used as directed by a healthcare professional to achieve therapeutic goals.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Who Can and Cannot Use Omeprazol Teva? (Official Regulatory Information)

Official regulatory documents define specific eligibility and non-eligibility criteria for Omeprazol Teva. Use is contraindicated and strictly prohibited for individuals with a known hypersensitivity to the active substance omeprazole, other substituted benzimidazoles, or any component of the formulation.

Absolute non-eligibility also applies if a patient is simultaneously taking antiretroviral medicines containing nelfinavir, rilpivirine, or atazanavir, as this concurrent use is contraindicated.

Age and Condition-Based Eligibility

Population Group Eligibility Status (Regulatory)
Infants (< 1 year) Not recommended or safety/efficacy not established
Children (1+ years) Eligible if ge 10 kg (for specific uses); ge 4 years for H. pylori treatment
Severe Hepatic Impairment Conditional use; dose reduction may be required, and combination therapy with clarithromycin is contraindicated
Pregnancy/Lactation Conditional use; requires professional risk-benefit assessment, as the substance is excreted in breast milk

No dose adjustment is typically required for the elderly or for patients with impaired renal function.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Omeprazol Teva's interaction profile is primarily defined by its effects on gastric pH and its action as a moderate inhibitor of the CYP2C19 enzyme.


Officially Documented Interaction Constraints:

Category
Contraindicated Combinations
Nelfinavir is contraindicated for concomitant use due to the risk of significantly decreased plasma concentrations of nelfinavir.

| Combinations Not Recommended / Avoidance Advised | | Clopidogrel use should be avoided or discouraged due to diminished antiplatelet effect caused by reduced formation of the active metabolite. | | Atazanavir, Posaconazole, and Erlotinib co-administration is not recommended, as omeprazole substantially reduces their absorption and efficacy. |

| Combinations Requiring Monitoring / Adjustment | | CYP2C19 Substrates: Drugs metabolized by CYP2C19 (e.g., Diazepam, Phenytoin, Warfarin) may have increased exposure, necessitating therapeutic drug monitoring (TDM) or dose reduction of the co-administered drug. | | Drugs with pH-Dependent Absorption: The absorption of agents like Digoxin is increased, requiring TDM, especially in elderly patients. | | Immunosuppressants: Co-administration with Tacrolimus requires frequent monitoring of Tacrolimus plasma concentrations and renal function. | | Antimetabolites: High-dose Methotrexate use may necessitate temporary withdrawal of omeprazole. | | Enzyme Modifiers: Concurrent use with inducers (e.g., Rifampin, St John’s Wort) decreases omeprazole levels, while inhibitors (e.g., Voriconazole) increase omeprazole levels. |

This structure reflects the regulatory requirement to address both altered absorption due to changes in gastric pH and metabolic interference via the CYP2C19 enzyme, guiding necessary avoidance or monitoring measures.

Mechanism of Action

The mechanism of Omeprazol Teva involves the irreversible inhibition of the H^+/ K^+-ATPase enzyme, commonly known as the gastric proton pump. This enzyme system, situated on the secretory surface of the stomach's parietal cells , represents the final step in hydrochloric acid secretion. Omeprazole functions as a prodrug, which is a weakly basic compound that concentrates selectively in the highly acidic canaliculi of the parietal cells. This acidic environment activates the drug, converting it into its active sulfenamide form. The sulfenamide then forms a covalent disulfide bond with specific cysteine residues on the proton pump. This irreversible molecular interaction blocks the pump's ability to exchange hydrogen ( H^+) and potassium ( K^+) ions, leading directly to a significant reduction in both basal and stimulated acid output. Since the inhibition is permanent, new acid secretion can only resume once the parietal cell synthesizes and inserts new proton pumps, which results in a prolonged duration of acid suppression and a sustained increase in intragastric pH (less acidic environment).

Dosage and Administration Information

How to Use Omeprazol Teva

The administration of Omeprazol Teva follows established clinical protocols. The medication is primarily administered via the oral route as a delayed-release capsule or enteric-coated tablet. This specialized formulation is designed to protect the active ingredient, omeprazole, from degradation by stomach acid until it reaches the small intestine for absorption.

Administration Timing and Constraints

Omeprazol Teva is typically taken once daily and must be administered before eating a meal, usually in the morning, to optimize its intended effect. The capsule must be swallowed whole with a liquid. A critical administration constraint is that the capsule or the pellets within must not be chewed or crushed under any circumstance, as this would compromise the protective gastro-resistant coating.

For patients unable to swallow the capsule intact, instructions permit opening the capsule and mixing the enteric-coated pellets with a small amount of cool, soft food, such as applesauce, for immediate consumption, followed by water.

Official Dosage and Duration Patterns

Usage Pattern Standard Adult Regimen Typical Duration
Most Acute Conditions (Ulcers, EE) 20 mg to 40 mg once daily 4 to 8 weeks
Maintenance of Healed EE 20 mg once daily Up to 12 months
Hypersecretory Conditions Starting dose 60 mg once daily Long-term, as clinically needed

Total daily dosages exceeding 80 mg for hypersecretory conditions are administered as divided doses given twice daily. Regarding patient populations, a dose reduction to 10 mg or 20 mg daily is specified for patients with severe hepatic impairment, while no dose adjustment is typically required for older adults or those with renal impairment. If a dose is missed, patients should take it as soon as possible, but skip the dose if it is almost time for the next scheduled dose; double doses must be avoided.

Recent Clinical Evidence

Recent Clinical Evidence Overview

Omeprazole, a proton pump inhibitor (PPI), has been extensively studied for its role in managing acid-related gastrointestinal disorders. It is indicated for conditions such as Gastroesophageal Reflux Disease (GERD), the healing of erosive esophagitis, treatment of peptic ulcers, and use in Helicobacter pylori eradication regimens.

Efficacy and Acid Suppression

Clinical trials consistently show that omeprazole effectively reduces the secretion of gastric acid. This effect is achieved through the inhibition of the H+/K+-ATPase enzyme (the proton pump) in the stomach's parietal cells. Research has demonstrated that daily oral doses of omeprazole (20 mg and higher) result in rapid and sustained acid control, reaching its maximum inhibitory effect within approximately four days of continuous daily dosing.

Studies comparing different formulations of omeprazole (e.g., capsule vs. tablet) have indicated equivalent effectiveness in controlling acid secretion and maintaining intragastric pH levels.

Safety and Long-Term Tolerability

The tolerability profile of omeprazole has been monitored across various populations. Common adverse events observed in clinical trials include headache, abdominal pain, nausea, and diarrhea.

For long-term use, observational studies have noted associations between prolonged PPI therapy and potential risks such as nutrient deficiencies (e.g., Vitamin B12 and magnesium) and an increased risk of enteric infections. However, the available evidence regarding a causal relationship between long-term omeprazole use and outcomes like chronic kidney disease or dementia remains inconsistent across research and does not establish a definitive causal link. Guidelines emphasize the importance of periodically reviewing the continued need for PPIs.

Frequently Asked Questions (FAQ)

Common questions about Omeprazol Teva (FAQ)

Q: Can Omeprazol Teva be used for the feeling of a lump in the throat?

Regulatory documents state that Omeprazol Teva is indicated for the treatment of symptomatic gastro-esophageal reflux disease (GERD) and reflux esophagitis. The feeling of a lump in the throat is often associated with the symptoms of GERD, which is treated by reducing stomach acid. The appropriateness of this medication for any condition is determined by a healthcare professional.

Q: Can Omeprazol Teva affect how supplements like iron or magnesium are absorbed?

Official product information indicates that this medicine may affect the absorption of certain substances because it reduces stomach acid (gastric pH). This effect may alter the uptake of supplements like magnesium and potentially lead to a Vitamin B12 deficiency with prolonged use. Information regarding nutrient levels and prolonged use should be reviewed by a healthcare professional.

Q: How fast does Omeprazol Teva start working to reduce stomach acid?

The medicine is generally considered to be rapidly acting, with acid control beginning shortly after the first dose. However, official information shows that the maximum acid-reducing effect is reached after approximately four days of taking the medicine continuously every day.

Q: How long does the effect of one dose of Omeprazol Teva typically last?

The medicine's action on the cells that produce stomach acid results in a prolonged duration of acid suppression. This sustained effect is why the medication is prescribed for use once daily to maintain acid control.

Q: Can older adults generally use Omeprazol Teva safely?

According to official product characteristics, no special dose adjustment is generally required for older adults compared to younger patients. However, co-administration with other medicines, such as Digoxin, may require regular monitoring by a healthcare professional.

Q: How does Omeprazol Teva compare to generic omeprazole in terms of regulatory research?

Omeprazol Teva is a licensed generic formulation containing the identical active ingredient as the original product. Regulatory agencies require all generic medicines to demonstrate bioequivalence. This means that they must be proven to work the same way in the body as the original drug.

Q: Does Omeprazol Teva treat the cause or just the symptoms of reflux?

The medicine works to suppress the production of gastric acid, which is the damaging component of reflux. By reducing acidity, it allows the stomach and esophageal lining to heal. It addresses the consequence of excessive acid but is not a treatment for the underlying mechanical cause of reflux itself.

Q: What official documents describe the ingredients in Omeprazol Teva?

The official documents that describe the ingredients are the Summary of Product Characteristics (SmPC) for healthcare professionals and the corresponding Patient Information Leaflet (PIL). The full list of excipients, or inactive ingredients, is typically detailed in a specific section of the SmPC.

Q: Is Omeprazol Teva the same as the Omeprazole available over the counter?

Both prescription Omeprazol Teva and the over-the-counter (OTC) version contain the identical active ingredient, omeprazole. The main difference lies in the approved uses defined by regulatory bodies: the prescription version is for diagnosed conditions, while the OTC version is specifically for the self-treatment of frequent heartburn symptoms.

Q: What is the difference between Omeprazol Teva and Esomeprazole?

Official product characteristics indicate that the active substance in Omeprazol Teva, omeprazole, is a racemic mixture, meaning it contains two types of molecules that are mirror images of each other. Esomeprazole is a distinct medicine that contains only one of those mirror-image forms (called the S-enantiomer).

Q: Are there any known food interactions with Omeprazol Teva?

Official instructions specify that the medicine should be taken before a meal for best absorption. The regulatory documents do not list any formal food interactions that would specifically affect the medicine's safety or efficacy, but certain foods or beverages may aggravate the underlying acid-related symptoms.

Q: Can you stop taking Omeprazol Teva suddenly?

Regulatory patient information indicates that suddenly stopping the medicine, especially if it has been used for a long period, may lead to temporary rebound acid production. This can cause the return or worsening of symptoms. A change to the duration or schedule of treatment requires the guidance of a healthcare professional.

Q: Can Omeprazol Teva affect driving ability or operation of machinery?

Official product documentation states that the medicine is not likely to affect the ability to drive or operate heavy machinery. However, rare side effects such as dizziness or visual disturbances may occur. If these effects occur, regulatory information suggests that driving or operating machinery should be avoided.

Q: Is it necessary to avoid coffee or spicy food while taking Omeprazol Teva?

There are no specific regulatory warnings regarding a direct drug interaction with coffee or spicy foods. However, general patient advice often recommends avoiding substances like coffee, spicy food, or alcohol. These items may irritate the stomach or stimulate acid production, potentially counteracting the beneficial effect of the medicine on the underlying condition.

Q: Does Omeprazol Teva cause weight gain or loss?

A review of the adverse reaction tables in regulatory documents indicates that weight gain or weight loss are not listed as common, uncommon, or rare documented side effects of the medicine.

Q: Where can I find the official patient leaflet for Omeprazol Teva?

The official patient information document, often called the Patient Information Leaflet (PIL) or Medication Guide, is provided by the pharmacist when the medicine is dispensed. It can also typically be found on the public websites of national regulatory authorities like the European Medicines Agency (EMA) or the US Food and Drug Administration (FDA).

How should Omeprazol Teva be stored and disposed of?

Official Storage and Disposal Instructions

Storing Omeprazol Teva requires strict adherence to labeled conditions to maintain product integrity and safety. Regulatory documents mandate storage below 30 C and emphasize the need to protect the medicine from moisture. The product must be stored in its original, tightly closed container and should not be used past the printed expiry date (EXP).

Required Storage and Handling

Condition Requirement
Temperature Store below 30 C (or 25 C for some formulations).
Protection Keep in original container, tightly closed, and protect from moisture.
Child Safety Keep out of the sight and reach of children.

Official Disposal Rules

Medicines disposal protocols require that Omeprazol Teva must not be thrown away via wastewater (flushed down the toilet or sink) or with general household waste. To protect the environment, unused or expired medicine must be returned to a pharmacist or utilize a government-approved drug take-back program for proper disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Omeprazol Teva found in:

A-Z Index: